Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Askin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Health and Technology|March 16, 2023
Artificial Intelligence Applied to clinical trials: opportunities and challengesScott Askin, Denis Burkhalter, Gilda Calado, et al.
Therapeutic Innovation & Regulatory Science|May 27, 2025
Recommendation Paper on Advancing the Use of Decentralised Elements in Clinical TrialsAlison Bond, Tracey Robertson, Christine Fletcher, et al.
BMC Medical Research Methodology|November 24, 2016
Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reportingPhilipp Bruland, Mark McGilchrist, Eric Zapletal, et al.
Clinical Pharmacology and Therapeutics|October 4, 2025
Regulatory Interactions and Learnings-RADIAL the Trials@Home Proof-of-Concept Trial on DecentralizationHelga Gardarsdottir, Hamidou Traore, Kate Huntley, et al.
NPJ Digital Medicine|March 29, 2023
Evolving regulatory perspectives on digital health technologies for medicinal product developmentSeya Colloud, Thomas Metcalfe, Scott Askin, et al.
Clinical Pharmacology and Therapeutics|April 30, 2022
Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' PerspectiveAmos J de Jong, Tessa I van Rijssel, Mira G P Zuidgeest, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Health and Technology|March 16, 2023
Artificial Intelligence Applied to clinical trials: opportunities and challengesScott Askin, Denis Burkhalter, Gilda Calado, et al.
Therapeutic Innovation & Regulatory Science|May 27, 2025
Recommendation Paper on Advancing the Use of Decentralised Elements in Clinical TrialsAlison Bond, Tracey Robertson, Christine Fletcher, et al.
BMC Medical Research Methodology|November 24, 2016
Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reportingPhilipp Bruland, Mark McGilchrist, Eric Zapletal, et al.
Clinical Pharmacology and Therapeutics|October 4, 2025
Regulatory Interactions and Learnings-RADIAL the Trials@Home Proof-of-Concept Trial on DecentralizationHelga Gardarsdottir, Hamidou Traore, Kate Huntley, et al.
NPJ Digital Medicine|March 29, 2023
Evolving regulatory perspectives on digital health technologies for medicinal product developmentSeya Colloud, Thomas Metcalfe, Scott Askin, et al.
Clinical Pharmacology and Therapeutics|April 30, 2022
Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' PerspectiveAmos J de Jong, Tessa I van Rijssel, Mira G P Zuidgeest, et al.
Pageof 1